Skip to main content
Fig. 4 | BMC Cardiovascular Disorders

Fig. 4

From: Coenzyme Q10 mitigates macrophage mediated inflammation in heart following myocardial infarction via the NLRP3/IL1β pathway

Fig. 4

IL1β production-related post-infarction cardiac inflammation was suppressed by CoQ10 treatment. (A) Analysis of gene expression in the infarct myocardium from each group of mice at 3 days after sham/LAD-ligation surgeries (Statistical analysis was performed using 2-way ANOVA with Sidak’s multiple comparison tests). Mice were treated with either vehicle or CoQ10. (B)(C) Representative images and analysis of the IL1β immunofluorescence staining in the Mac3-positive macrophages from mice treated with vehicle or CoQ10 at 28 days after LAD ligation (Statistical analysis was performed using a two-tailed unpaired Student’s t-test). 630×. Scale bars indicate 20 μm. (D) Representative flow cytometry analysis of left ventricles after sham/LAD ligation surgeries. Cells were defined as neutrophils (Neut, CD45.2+CD64Ly6G+), monocytes (Mono, CD45.2+Ly6GCD64intLy6Chi), macrophages (Mac, CD45.2+Ly6GCD64+Ly6Clo), or CCR2+ macrophages (CCR2+Mac, CD45.2+Ly6GCD64+Ly6CloCCR2+). (E) Quantification of the mean fluorescence intensity (MFI) of IL-1β in the CCR2+ macrophages of mice 3 days after LAD ligation, either treated with vehicle or CoQ10 (Statistical analysis was performed using a two-tailed unpaired Student’s t-test). MI: myocardial infarction; CoQ10: Coenzyme Q10; MFI: mean fluorescent intensity. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page